Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
WT-1312 by Wintermute Biomedical for Herpes Zoster (Shingles): Likelihood of Approval
WT-1312 is under clinical development by Wintermute Biomedical and currently in Phase I for Herpes Zoster (Shingles). According to GlobalData,...